Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

RENAISSANCERE HOLDINGS LTD (RNR)

  • Business News
  • May 06, 2026, 20:29 UTC
  • 2
  • 1 comments

RenaissanceRe Holdings Ltd. Announces Board of Directors Changes, Declares Quarterly Dividend and Approves Renewal of Share Repurchase Program

Market reaction Comment Full text

ORMAT TECHNOLOGIES,INC (ORA)

  • Business News
  • May 06, 2026, 20:27 UTC
  • 2
  • 1 comments

Immediate Report

Market reaction Comment Full text

IMMUTEP LTD (IMMP)

  • Business News
  • May 06, 2026, 20:26 UTC
  • 2
  • 1 comments

IMMP Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Immutep Limited

Market reaction Comment Full text

FS KKR CAPITAL CORP (FSK)

  • Business News
  • May 06, 2026, 20:24 UTC
  • 2
  • 1 comments

FSK Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against FS KKR Capital Corp.

Market reaction Comment Full text

ALLIENT INC (ALNT)

  • Business News
  • May 06, 2026, 20:23 UTC
  • 2
  • 1 comments

Allient Increases Quarterly Cash Dividend 33% to 0.04 per Share

Market reaction Comment Full text

NL INDUSTRIES INC (NL)

  • Business News
  • May 06, 2026, 20:20 UTC
  • 2
  • 1 comments

NL REPORTS FIRST QUARTER 2026 RESULTS

Market reaction Comment Full text

HAMILTON INSURANCE GROUP, LTD. (HG)

  • Business News
  • May 06, 2026, 20:20 UTC
  • 2
  • 1 comments

Peter W. Wilson Joins Hamilton Board of Directors

Market reaction Comment Full text

METLIFE INC (MET)

  • Business News
  • May 06, 2026, 20:20 UTC
  • 2
  • 1 comments

MetLife CFO John McCallion Provides First Quarter 2026 Financial Update Video

Market reaction Comment Full text

PEPSICO INC (PEP)

  • Business News
  • May 06, 2026, 20:20 UTC
  • 2
  • 1 comments

PepsiCo Declares Quarterly Dividend

Market reaction Comment Full text

CONTEXT THERAPEUTICS INC. (CNTX)

  • Business News
  • May 06, 2026, 20:18 UTC
  • 4
  • 1 comments

Context Therapeutics Reports First Quarter 2026 Operating and Financial Results

Market reaction Comment Full text
  • Previous
  • 188
  • 189
  • 190
  • 191
  • 192
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158461)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin